2 completed. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 2 | Completed 2 |
Follow Endocine: new trials by email Literature Review of Endocine trials Research Report on Endocine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Assess the Safety, Tolerability and Immune Response Following Vaccination With Immunose™ FLU 15 µg HA/strain and 1% Endocine™, 15 µg HA/strain and 2% Endocine™, 15 µg HA/strain - Influenza, Human | Phase 1 / Phase 2 | Completed | Eurocine Vaccines AB | 162 | 2016-09-01 | 2019-02-21 |
| Intranasal Modified Vacc-4x Gag Peptides With Endocine as Adjuvant Vacc-4x low dose, Vacc-4x medium dose, Vacc-4x high dose - HIV Infection | Phase 1 / Phase 2 | Completed | Oslo University Hospital | 24 | 2011-11-01 | 2012-06-20 |
HIV Infections (1) · Influenza, Human (1)
Eurocine Vaccines AB (1) · Oslo University Hospital (1)
Norway (1) · Sweden (1)
Cornelia Lif-Tiberg, MD (1) · Dag Kvale, Professor/MD (1)